Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Article   |    
Am J Psychiatry 1958;115:402-409.
text A A A
PDF of the full text article.

1. Chemotherapeutic remission of melancholia can now be accomplished, in a majority of cases, without resort to ECT, by carefully supervised administration of Marsilid, Roche iproniazid (1-isonicotinyl, 2-isopropylhydrazine phosphate).2. However, until methods are discovered for accelerating Marsilid's effectiveness in the first few days of treatment, the aggressively suicidal case must still be given ECT, which assures most immediate remission of depression. Each case must be carefully evaluated when first seen.3. This chemical, introduced 6 years ago for the treatment of tuberculosis, is now found to possess much wider scope in medicine including therapeutic efficacy in some apathetic and withdrawn, seclusive types.4. A major factor in the effectiveness of this chemical in accomplishing psychic energization is the prevention of inactivation of the brain-stored powerful hormone serotonin, by its amine oxidase inhibitor action, but other equally powerful chemical Interactions may be simultaneously involved.5. The powerful chemical forces released may Induce serious complications unless the physician psychiatrist is constantly alert to the need for frequent alteration of dosage as indicated by his physical findings.6. Excellent antidotes for certain complications are available.7. A by-product of major significance is the enhancement of psychotherapy through increased spontaneity, improved sense of well being and resulting betterment of rapport.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Web of Science® Times Cited: 9

Related Content
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
The American Psychiatric Publishing Textbook of Psychopharmacology, 4th Edition > Chapter 1.  >
DSM-5™ Clinical Cases > Chapter 3.  >
DSM-5™ Clinical Cases > Chapter 3.  >
DSM-5™ Clinical Cases > Chapter 7.  >
Topic Collections
Psychiatric News